Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 22643227)

1.

In vitro and in vivo evaluation of N,N,N-trimethylphytosphingosine-iodide (TMP) in liposomes for the treatment of angiogenesis and metastasis.

Song CK, Lee JH, Jahn A, Choi MJ, Namgoong SK, Hong SS, Chong S, Shim CK, Chung SJ, Kim DD.

Int J Pharm. 2012 Sep 15;434(1-2):191-8. doi: 10.1016/j.ijpharm.2012.05.042. Epub 2012 May 27.

PMID:
22643227
3.

Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.

Chen L, Lu Y, Wu JM, Xu B, Zhang LJ, Gao M, Zheng SZ, Wang AY, Zhang CB, Zhang WW, Lei N.

Biochem Biophys Res Commun. 2009 Aug 21;386(2):374-9. doi: 10.1016/j.bbrc.2009.06.042. Epub 2009 Jun 11.

PMID:
19523924
4.

Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.

Zhang LJ, Chen L, Lu Y, Wu JM, Xu B, Sun ZG, Zheng SZ, Wang AY.

Eur J Pharmacol. 2010 Sep 25;643(2-3):195-201. doi: 10.1016/j.ejphar.2010.06.045. Epub 2010 Jul 11.

PMID:
20621088
5.

Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma.

Yang JH, Hu J, Wan L, Chen LJ.

Asian Pac J Cancer Prev. 2014;15(1):167-74.

6.

Acidic mucopolysaccharide from Holothuria leucospilota has antitumor effect by inhibiting angiogenesis and tumor cell invasion in vivo and in vitro.

Zhang W, Lu Y, Xu B, Wu J, Zhang L, Gao M, Zheng S, Wang A, Zhang C, Chen L, Lei N.

Cancer Biol Ther. 2009 Aug;8(15):1489-99. Epub 2009 Aug 8.

7.

Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.

Paschoalin T, Carmona AK, Rodrigues EG, Oliveira V, Monteiro HP, Juliano MA, Juliano L, Travassos LR.

Mol Cancer. 2007 Jul 9;6:44.

8.

A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.

Rastelli L, Valentino ML, Minderman MC, Landin J, Malyankar UM, Lescoe MK, Kitson R, Brunson K, Souan L, Forenza S, Goldfarb RH, Rabbani SA.

Int J Oncol. 2011 Aug;39(2):401-8. doi: 10.3892/ijo.2011.1040. Epub 2011 May 11.

PMID:
21567086
9.

Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.

Hamsa TP, Kuttan G.

Eur J Pharmacol. 2010 Dec 15;649(1-3):64-73. doi: 10.1016/j.ejphar.2010.09.010. Epub 2010 Sep 19.

PMID:
20858484
10.

Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions.

Nakajima M, Hayashi K, Katayama K, Amano Y, Egi Y, Uehata M, Goto N, Kondo T.

Eur J Pharmacol. 2003 Jan 17;459(2-3):113-20.

PMID:
12524136
11.

A recombinant peptide, hirudin, potentiates the inhibitory effects of stealthy liposomal vinblastine on the growth and metastasis of melanoma.

Guo RR, Liu Y, Lu WL, Zhao JH, Wang XQ, Zhang H, Wang JC, Zhang X, Zhang Q.

Biol Pharm Bull. 2008 Apr;31(4):696-702.

12.

Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth.

Kinet V, Nguyen NQ, Sabatel C, Blacher S, Noël A, Martial JA, Struman I.

Cancer Lett. 2009 Nov 1;284(2):222-8. doi: 10.1016/j.canlet.2009.04.030. Epub 2009 May 26.

PMID:
19473755
13.

Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa.

Yamamoto K, Kimura T, Sugitachi A, Matsuura N.

Biol Pharm Bull. 2009 Feb;32(2):259-63.

14.

Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.

Nakajima M, Hayashi K, Egi Y, Katayama K, Amano Y, Uehata M, Ohtsuki M, Fujii A, Oshita K, Kataoka H, Chiba K, Goto N, Kondo T.

Cancer Chemother Pharmacol. 2003 Oct;52(4):319-24. Epub 2003 May 29.

PMID:
12783205
15.

Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.

Sheu JR, Fu CC, Tsai ML, Chung WJ.

Anticancer Res. 1998 Nov-Dec;18(6A):4435-41.

PMID:
9891506
16.

Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis.

Chen W, Lu Y, Wu J, Gao M, Wang A, Xu B.

Cancer Chemother Pharmacol. 2011 Apr;67(4):799-808. doi: 10.1007/s00280-010-1378-x. Epub 2010 Jun 19.

PMID:
20563582
17.

Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.

Sun J, Blaskovich MA, Jain RK, Delarue F, Paris D, Brem S, Wotoczek-Obadia M, Lin Q, Coppola D, Choi K, Mullan M, Hamilton AD, Sebti SM.

Cancer Res. 2004 May 15;64(10):3586-92.

18.

The antitumour activities induced by pegylated liposomal cytochalasin D in murine models.

Huang FY, Mei WL, Li YN, Tan GH, Dai HF, Guo JL, Wang H, Huang YH, Zhao HG, Zhou SL, Li L, Lin YY.

Eur J Cancer. 2012 Sep;48(14):2260-9. doi: 10.1016/j.ejca.2011.12.018. Epub 2012 Jan 16.

PMID:
22257793
19.

Antiangiogenic and antitumor activities of IL-27.

Shimizu M, Shimamura M, Owaki T, Asakawa M, Fujita K, Kudo M, Iwakura Y, Takeda Y, Luster AD, Mizuguchi J, Yoshimoto T.

J Immunol. 2006 Jun 15;176(12):7317-24.

20.

FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.

Sola F, Farao M, Ciomei M, Pastori A, Mongelli N, Grandi M.

Invasion Metastasis. 1995;15(5-6):222-31.

PMID:
8765197
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk